RxDoctor Payments Data

Duc Trieu, MD

Obstetrics & Gynecology · South Boston, VANPI 1659317576

Payments from drug & device makers

$1,799in general payments, 2019–2025

Across 124 payments — averaging $14.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$383
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$331
  • Bayer$275
  • Novo Nordisk$227
  • Indivior Inc.$163
  • Lilly USA, LLC$158
  • plus $263 from 11 others

What the payments were for

  • Food & beverage$1,799100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,799 in reported general payments places this provider in the 75th percentile of 992 obstetrics & gynecology providers in Virginia.

See all obstetrics & gynecology providers in Virginia

Medicare billing

Part B allowed, 2024
$47,233
Medicare patients
155
Services billed
536

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide28$57,840
SublocadeBuprenorphine11$22,707
TrulicityDulaglutide23$21,845
VraylarCariprazine Hcl12$17,581
JanuviaSitagliptin Phosphate15$15,318
FarxigaDapagliflozin Propanediol16$14,388
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl63$11,249
Combivent RespimatIpratropium/Albuterol Sulfate12$5,922
Ezetimibe29$1,481
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$1,448
Wixela InhubFluticasone Propion/Salmeterol12$1,021
Gabapentin142$1,001
Venlafaxine Hcl ErVenlafaxine Hcl27$981
Albuterol Sulfate HfaAlbuterol Sulfate48$916
Levocetirizine Dihydrochloride114$812

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$227$57,84028 claims
Indivior Inc.Sublocade$163$22,70711 claims
Lilly USA, LLCTrulicity$158$21,84523 claims
AbbVieVraylar$383$17,58112 claims
MerckJanuvia$24$15,31815 claims
AstraZenecaFarxiga$55$14,38816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 992 obstetrics & gynecology providers in Virginia.

Other obstetrics & gynecology in South Boston

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →